SIC
ELAN icon

Samalin Investment Counsel’s Elanco Animal Health ELAN Stock Holding History

Samalin Investment Counsel’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,131
Closed -$283K – 226
2020
Q3 		$283K Buy
+10,131
New +$257K 0.25% 132
2020
Q1 		– Sell
-3,394
Closed -$99K – 243
2019
Q4 		$99K Buy
+3,394
New +$92.2K 0.08% 231

Other funds holding ELAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Samalin Investment Counsel's ELAN Position: Q4 2020 in Review

Samalin Investment Counsel sold out of Elanco Animal Health (ELAN) in Q4 2020, closing a stake of 10,131 shares — an estimated $283K sold.

Samalin Investment Counsel first reported a position in ELAN in Q4 2019 and held it in 2 quarters. The position peaked at $283K in Q3 2020. 440 funds tracked by Wall St. Rank hold ELAN as of Q4 2020.

  • Samalin Investment Counsel reported no remaining Elanco Animal Health position as of Q4 2020 after selling out during the quarter.
  • Samalin Investment Counsel sold 10,131 Elanco Animal Health shares in Q4 2020, an estimated $283K.
  • Samalin Investment Counsel first reported a position in Elanco Animal Health in Q4 2019 and held it in 2 quarters.
  • Samalin Investment Counsel's Elanco Animal Health position peaked at $283K in Q3 2020.
  • 440 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2020.

Based on Samalin Investment Counsel's 13F filing for Q4 2020, filed 9 Feb 2021.